Concentric by Ginkgo and Illumina collaborate to deploy biosurveillance technologies around the world
BOSTON and SAN DIEGO, Jan. 15, 2024 /PRNewswire/ -- Concentric by Ginkgo, the biosecurity and public health unit of Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that it has entered into a Co-Marketing Agreement with Illumina, Inc. (Nasdaq: ILMN), a global leader in DNA sequencing and array-based technologies, to partner on expanding biosecurity capabilities globally.
- Illumina is a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets.
- Illumina offers a range of leading next-generation sequencing instruments, consumables, and software to understand pathogens in ways not previously possible.
- Together, Concentric and Illumina are working to help ensure that nations worldwide are equipped and empowered, locally and sustainably.
- "Illumina is proud to partner with Concentric by Ginkgo to empower countries to protect the health of their citizens from infectious threats."